Cargando…
Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis
Non-alcoholic fatty liver disease (NAFLD) is a wide-spread chronic liver condition that places patients at risk of developing cardiovascular diseases and may progress to cirrhosis or hepatocellular carcinoma if untreated. Challenges in clinical and basic research are caused by poor understanding of...
Autores principales: | Ryaboshapkina, Maria, Hammar, Mårten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617840/ https://www.ncbi.nlm.nih.gov/pubmed/28955037 http://dx.doi.org/10.1038/s41598-017-10930-w |
Ejemplares similares
-
Tissue-specific genes as an underutilized resource in drug discovery
por: Ryaboshapkina, Maria, et al.
Publicado: (2019) -
Sample size calculation for a NanoString GeoMx spatial transcriptomics experiment to study predictors of fibrosis progression in non-alcoholic fatty liver disease
por: Ryaboshapkina, Maria, et al.
Publicado: (2023) -
SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
por: Mazzolini, Guillermo, et al.
Publicado: (2018) -
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021) -
Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis
por: Ma, Mengyao, et al.
Publicado: (2021)